Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07030959 · ClinicalTrials.gov registry record · Phase 1

Study of AUBE00 in Patients With Solid Tumors

A Phase 1 study of Solid Tumors, sponsored by Chugai Pharmaceutical.

Recruiting
Registry status
Phase 1
Development phase
130
Enrollment target
4
Study locations

NCT07030959 is a Phase 1 study of Solid Tumors that is actively recruiting participants, run by Chugai Pharmaceutical. The registered enrollment target is 130 participants, below the 284-participant average among 125 other Solid Tumors trials with a reported enrollment target (54% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07030959, a Phase 1 study of Solid Tumors, is actively recruiting participants, sponsored by Chugai Pharmaceutical.

RECRUITING
Registry status
Phase 1
Development phase
130 participants
Enrollment target
4
Study locations

Study Summary

This is a first-in-human, Phase I, open-label, multicenter, multinational study, designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity, and anti-tumor activity of AUBE00 in patients with locally advanced or metastatic solid tumors.The total number of patients in this study will be approximately 90 to 130.

Conditions Studied

Solid Tumors

Interventions

  • DRUG Cetuximab
  • DRUG AUBE00

Study Locations (4)

Michigan

  • South Texas Accelerated Research Therapeutics (START) Midwest - Grand Rapids

Texas

  • The University of Texas MD Anderson Cancer Center - Houston

Chiba

  • National Cancer Center Hospital East - Kashiwa

Tokyo

  • National Cancer Center Hospital - Chuo-ku

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2025-06-05
Est. Completion 2029-12-31
Phase Phase 1

Sponsor

Chugai Pharmaceutical

17 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07030959

The ClinicalTrials.gov registry entry for NCT07030959 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 284-participant average among 125 other Solid Tumors trials with a reported enrollment target (54% lower). The listed sponsor is Chugai Pharmaceutical, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Solid Tumors appearing as the primary indexed condition, and to 2 interventions - of which Cetuximab is the first listed.

NCT07030959 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Michigan, Texas, Chiba.

Frequently Asked Questions

What is clinical trial NCT07030959 about?

NCT07030959 is a clinical study titled "Study of AUBE00 in Patients With Solid Tumors". This is a first-in-human, Phase I, open-label, multicenter, multinational study, designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity, and anti-tumor activity of AUBE00 in patients with locally advanced or metastatic solid tumors.The total numbe...

What is the current status of trial NCT07030959?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 130 participants. The study started on 2025-06-05. Estimated completion is 2029-12-31.

What conditions does trial NCT07030959 study?

This clinical trial studies the following conditions: Solid Tumors.

What interventions are being tested in trial NCT07030959?

The interventions under investigation include: Cetuximab (DRUG), AUBE00 (DRUG).

Who is sponsoring clinical trial NCT07030959?

This trial is sponsored by Chugai Pharmaceutical, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07030959 being conducted?

This trial has 4 study locations across Michigan, Texas, Chiba, Tokyo. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Solid Tumors

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Solid Tumors

All registered trials for this condition

Michigan

All trials with a study site in Michigan

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.